Status:
COMPLETED
Effect of Alcohol on Cephalic Phase Reflex and Gene Expression
Lead Sponsor:
TNO
Conditions:
Type 2 Diabetes
Inflammation
Eligibility:
FEMALE
Up to 65 years
Phase:
NA
Brief Summary
Moderate alcohol consumption has consistently been associated with lowered risk of developing type two diabetes mellitus compared to abstainers and heavy drinkers. However, the underlying mechanism fo...
Detailed Description
Moderate alcohol consumption has consistently been associated with lowered risk of developing type two diabetes mellitus compared to abstainers and heavy drinkers. However, the physiological mechanism...
Eligibility Criteria
Inclusion
- Healthy as assessed by the health and lifestyle questionnaire (P8009 F02), physical examination and results of the pre-study laboratory tests
- Caucasian postmenopausal females aged 65 years or younger at Day 01 of the study.
- Body Mass Index (BMI) of 18 - 26 or 27 - 35 kg/m2.
- Postmenopausal as assessed by self reported absence of menstrual periods for at least 12 months.
- Alcohol consumption ≥ 5 and ≤ 22 standard units/week.
- Normal Dutch eating habits as assessed by P8009 F02.
- Voluntary participation.
- Having given written informed consent.
- Willing to comply with the study procedures, including refrain from drinking alcoholic drinks other then the wine provided by TNO during the entire study.
- Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years.
- Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned.
Exclusion
- Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study.
- Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous, inhalatory administration of substances.
- Having a history of medical or surgical events that may significantly affect the study outcome, particularly metabolic or endocrine disease and gastrointestinal disorders.
- Use of medication that may affect the outcome of the study parameters.
- Having a family history of alcoholism.
- Smoking.
- Not having appropriate veins for blood sampling/cannula insertion according to TNO.
- Reported unexplained weight loss or gain in the month prior to the pre-study screening.
- Reported slimming or medically prescribed diet.
- Reported vegan, vegetarian or macrobiotic.
- Recent blood donation (\<1 month prior to the start of the study).
- Not willing to give up blood donation during the study.
- Personnel of TNO Quality of Life, their partner and their first and second degree relatives.
- Not having a general practitioner.
- Not willing to accept information transfer concerning participation in the study, or information regarding her health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner.
- Not willing your general practitioner to be notified upon participation in this study
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00652405
Start Date
May 1 2008
End Date
July 1 2008
Last Update
August 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TNO Quality of Life
Zeist, Netherlands, 3700AJ